Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
2,618
Patients in the RAF group will have routine angiography follow-up at 12 months after revascularization.
Patients in the RCF group will have routine clinical follow-up at 12 months after revascularization, and the physician will decide whether further invasive testing is needed.
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
RECRUITINGComposite endpoint of all-cause death, myocardial infarction, or hospitalization for unstable angina
The rate of a composite endpoint of all-cause death, myocardial infarction, or hospitalization for unstable angina
Time frame: 24 months
Composite endpoint of all-cause death, myocardial infarction, or hospitalization for unstable angina
The rate of a composite endpoint of all-cause death, myocardial infarction, or hospitalization for unstable angina
Time frame: 60 months
All-cause death
The rate of all-cause death
Time frame: 24 and 60 months
Myocardial infarction
The rate of myocardial infarction
Time frame: 24 and 60 months
Hospitalization for unstable angina
The rate of hospitalization for unstable angina
Time frame: 24 and 60 months
Cardiac death
The rate of hospitalization for cardiac death
Time frame: 24 and 60 months
Invasive angiography during follow-up
The rate of invasive angiography during follow-up
Time frame: 24 and 60 months
Any revascularization
The rate of any revascularization during follow-up (ischemia-driven vs. all-cause)
Time frame: 24 and 60 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Revascularization of any target vessel/lesion
The rate of revascularization of any target vessel/lesion
Time frame: 24 and 60 months
Revascularization of any non-target vessel/lesion
The rate of revascularization of any non-target vessel/lesion
Time frame: 24 and 60 months
Health Economics Analysis (cost-effectiveness)
Time frame: 24 and 60 months